Evidence map›Paper›PMID 41876796›Full record

ArticleEMBO molecular medicine2026

A skin colonizer disrupts inflammatory and humoral immune defenses in hidradenitis suppurativa.

Viviane A Agbogan, Florence Bugault, Laure Guenin-Macé, Inta Gribonika, Cyril Planchais, Jean-David Morel, Jérémie Delaleu, P Juliana Pérez-Chaparro, Michael Atlan, Maïa Delage and 5 more

Abstract read
In one paragraph

Article in EMBO molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Viviane A AgboganInstitut Pasteur, Université Paris Cité, Inserm U1224, Immunobiology and Therapy Unit, Paris, France.ORCID 0000-0001-9164-8774
Florence Bugault *Institut Pasteur, Université Paris Cité, Inserm U1224, Immunobiology and Therapy Unit, Paris, France.
Laure Guenin-Macé *Institut Pasteur, Université Paris Cité, Inserm U1224, Immunobiology and Therapy Unit, Paris, France. laure.guenin-mace@pasteur.fr.ORCID 0000-0002-9791-5308
Inta GribonikaMetaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.ORCID 0000-0002-5694-1315
Cyril PlanchaisInstitut Pasteur, Université Paris Cité, Humoral Immunology Unit, Paris, France.ORCID 0000-0002-5142-7253
Jean-David MorelEcole Polytechnique Fédérale de Lausanne, Institute of Bioengineering, Laboratory of Integrative Systems Physiology, Lausanne, Switzerland.ORCID 0000-0002-7122-9924
Jérémie DelaleuMetaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.ORCID 0000-0002-8492-4248
P Juliana Pérez-ChaparroNIAID Microbiome Program, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Michael AtlanTenon Hospital, Institut Universitaire de Cancérologie, Department of Plastic, Reconstructive and Aesthetic Surgery, Assistance Publique-Hôpitaux de Paris, Paris, France.
Maïa DelageInstitut Pasteur, Université Paris Cité, Medical Center, Paris, France.
Aude NassifInstitut Pasteur, Université Paris Cité, Medical Center, Paris, France.
Hugo MouquetInstitut Pasteur, Université Paris Cité, Humoral Immunology Unit, Paris, France.ORCID 0000-0002-4230-610X
Yasmine BelkaidMetaorganism Immunity Section, Laboratory of Host Immunity and Microbiome, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.
Olivier Join-LambertUniv de Caen Normandie, Univ Rouen Normandie, INSERM, DYNAMICURE UMR 1311, CHU Caen, Department of Microbiology, F-14000, Caen, France. olivier.join-lambert@unicaen.fr.ORCID 0000-0002-4888-8630
Caroline DemangelInstitut Pasteur, Université Paris Cité, Inserm U1224, Immunobiology and Therapy Unit, Paris, France. caroline.demangel@pasteur.fr.ORCID 0000-0001-7848-586X

Funding

Agence Nationale de la Recherche (ANR) ANR-21-CE15-0004-01
6 · The paper itself

Abstract

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease associated with a polybacterial dysbiosis devoid of a known pathogen. Here, we report that HS patients mount IgA and IgG responses against skin colonizers, notably Porphyromonas uenonis (Pu), a rare species selectively enriched in severe disease. In these patients, Pu foci are detected in the epidermis, surrounded by IgA deposits, and anti-Pu IgGs cross-react with self-antigens expressed by healthy keratinocytes. Using healthy human skin explants, we demonstrate that patient-derived Pu can cross an intact epidermal barrier, infect and persist within keratinocytes, triggering their expression of pro-inflammatory mediators. In contrast, topical application of Pu on immunocompetent mice elicit cutaneous and systemic humoral immune responses without tissue infection. These findings uncover an impaired innate immune control of Pu in HS patients, linking keratinocyte infection to skin inflammation and humoral autoimmunity. They underscore the potential of targeting cutaneous dysbiosis as a strategy to limit HS progression.

Indexed as

Bacteroidaceae InfectionsHidradenitis SuppurativaImmunity, HumoralSkinAnimalsAntibodies, BacterialFemaleHumansImmunoglobulin AImmunoglobulin GInflammationKeratinocytesMiceSkin MicrobiomeAntibodies, BacterialImmunoglobulin AImmunoglobulin GAntibodiesBacteriaInflammationKeratinocyteSkin

Identifiers

PMID41876796
PMCPMC13179376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.